Predict your next investment

HEALTHCARE | Medical Facilities & Services
angloarabian-healthcare.com

See what CB Insights has to offer

Stage

Acq - Fin | Alive

About Anglo Arabian Healthcare

Anglo Arabian Healthcare is an integrated healthcare provider that has been established to provide safe and affordable healthcare to low and middle income groups as well as premium, high quality healthcare to more affluent communities.In June 2013, Anglo Arabian Healthcare was acquired by Waha Capital. The valuation of Anglo Arabian Healthcare was undisclosed. Other terms of the deal were not released.

Anglo Arabian Healthcare Headquarter Location

Office 101, 1st Floor Ibn Rushd, Building 33

Dubai,

United Arab Emirates

+971 563743676

Latest Anglo Arabian Healthcare News

Waha Capital completes sale of stake in UAE diagnostics firm

Dec 20, 2017

ABU DHABI, 1 hours, 26 minutes ago Waha Capital, a leading Abu Dhabi-based investment company, through its UAE healthcare subsidiary Anglo Arabian Healthcare (AAH) has completed the sale of its full equity stake in Proficiency Healthcare Diagnostics (PHD) to Al Borg Medical Laboratories, the GCC’s largest chain of private laboratories. The transaction, which was previously announced on May 21, 2017, involves an equity sale price of approximately Dh184 million for 100 per cent of PHD, with the net impact on Waha Capital being an accounting gain of approximately Dh94 million which will be recorded in the company’s Q4 2017 financial statements, Waha said. AAH acquired a 70 per cent stake in PHD in April 2013 and then increased its stake in the business to 93 per cent. During the holding period, PHD solidified its position as a leading independent diagnostic services provider in the UAE. The company has expanded its footprint since AAH’s acquisition by adding new branches in Al Ain, Dubai and the Western Region, which led to a more than doubling of revenues and earnings since 2013. “Waha Capital entered PHD at a key stage in the company’s growth trajectory, supporting the business in achieving impressive scale,” said Salem Rashid Al Noaimi, Chief Executive Officer and Managing Director of Waha Capital. Al Noaimi added: “The transaction crystalises significant value creation achieved by Waha Capital and AAH. We look forward to delivering more success under AAH as we continue to expand the group’s scale in the premium and affordable care segments.”    Dr Fawaz Al Bishri, Chairman of Al Borg Medical Laboratories, said: “The two companies are leaders in their respective markets and the combined company in the UAE, with a network of 12 laboratories, will be a clear market leader in the private independent laboratory space. Such a combination will allow Al Borg and PHD to benefit from synergies and greater scale, thereby allowing us to accelerate our growth plans across the Middle East.”   Anglo Arabian Healthcare, which is a seed asset in Waha Capital’s private equity business, operates multiple healthcare platforms with 35 healthcare assets across Abu Dhabi, Dubai, Sharjah, Ajman and Ras Al Khaimah. Al Borg Medical Laboratories is the largest private laboratory chain in the GCC, offering a wide range of routine and specialty tests to individuals, hospitals, clinics, insurance companies and corporates. As of December 2016, the company had 52 laboratories, 1,150 personnel, and conducted over 7.5 million tests across eight countries in the GCC and Africa. - TradeArabia News Service

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.